RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Alterity Therapeutics Stock

Alterity Therapeutics Equity 2024

Alterity Therapeutics Equity

0 AUD

Ticker

ATH.AX

ISIN

AU0000043945

WKN

A2PHDZ

In 2024, Alterity Therapeutics's equity was 0 AUD, a -100% increase from the 35.47 M AUD equity in the previous year.

Alterity Therapeutics Aktienanalyse

What does Alterity Therapeutics do?

Alterity Therapeutics Ltd is an Australian company specializing in the discovery and development of therapeutics for neurodegenerative diseases. The company's history dates back to 1997 when it was established under the name Prana Biotechnology Limited. Alterity Therapeutics' business model is based on the research of protein aggregates responsible for neurodegenerative diseases. The company primarily focuses on developing drugs targeting the breakdown of these protein aggregates to minimize the effects of diseases such as Parkinson's, Alzheimer's, and Huntington's. The company has several divisions specializing in various aspects of product development, including preclinical research, clinical development, and commercial marketing. Alterity Therapeutics has several products in various stages of development. One of its leading products is PBT434, a drug that aims to prevent protein aggregates in the brain and target the treatment of Parkinson's disease. The drug has already been tested in clinical trials and has shown promising results. In addition to PBT434, the company also has other promising drugs in development, including PBT519, targeting the treatment of Alzheimer's disease, and PBT2, targeting the treatment of Huntington's disease. Alterity Therapeutics aims to minimize the impact of neurodegenerative diseases and improve the quality of life for millions of patients worldwide. The company collaborates with leading medical and academic institutions to develop innovative therapeutics that meet the needs of patients and clinicians. Overall, Alterity Therapeutics offers a promising pipeline of drugs that could play a significant role in the treatment of neurodegenerative diseases. The company has become a major player in the industry and has the potential to make a significant impact in the fight against these serious illnesses. Alterity Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Alterity Therapeutics's Equity

Alterity Therapeutics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Alterity Therapeutics's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Alterity Therapeutics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Alterity Therapeutics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Alterity Therapeutics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Alterity Therapeutics stock

What is the equity of Alterity Therapeutics this year?

Alterity Therapeutics has equity of 0 AUD this year.

What was the equity of Alterity Therapeutics compared to the previous year?

The equity of Alterity Therapeutics has increased/decreased by -100% decreased compared to the previous year.

What impact does a high equity have on investors of Alterity Therapeutics?

A high equity is advantageous for investors of Alterity Therapeutics as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Alterity Therapeutics?

A low equity can be a risk for investors of Alterity Therapeutics, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Alterity Therapeutics affect the company?

An increase in equity of Alterity Therapeutics can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Alterity Therapeutics affect the company?

A reduction in equity of Alterity Therapeutics can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Alterity Therapeutics?

Some factors that can affect the equity of Alterity Therapeutics include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Alterity Therapeutics so important for investors?

The equity of Alterity Therapeutics is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Alterity Therapeutics take to change the equity?

To change equity, Alterity Therapeutics can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Alterity Therapeutics pay?

Over the past 12 months, Alterity Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Alterity Therapeutics is expected to pay a dividend of 0 AUD.

What is the dividend yield of Alterity Therapeutics?

The current dividend yield of Alterity Therapeutics is .

When does Alterity Therapeutics pay dividends?

Alterity Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Alterity Therapeutics?

Alterity Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Alterity Therapeutics?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Alterity Therapeutics located?

Alterity Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Alterity Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Alterity Therapeutics from 9/25/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 9/25/2024.

When did Alterity Therapeutics pay the last dividend?

The last dividend was paid out on 9/25/2024.

What was the dividend of Alterity Therapeutics in the year 2023?

In the year 2023, Alterity Therapeutics distributed 0 AUD as dividends.

In which currency does Alterity Therapeutics pay out the dividend?

The dividends of Alterity Therapeutics are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Alterity Therapeutics

Our stock analysis for Alterity Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Alterity Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.